Vomikind-MD 2 Tablet
Marketer
Mankind Pharma Ltd
Salt Composition
Ondansetron (2mg)
Overview Vomikind-MD 2 Tablet
PediaNausea-2 is a pediatric medication used to alleviate nausea and vomiting. Its primary application is managing nausea and vomiting associated with surgery, chemotherapy, radiation therapy, and gastrointestinal infections. It's also effective for vomiting induced by medications such as analgesics. PediaNausea-2 can be administered before or after meals. For chemotherapy-induced vomiting, give it 30 minutes prior to treatment. Administer 1-2 hours before radiotherapy and 1 hour before surgery to prevent post-procedural vomiting. If your child vomits the medication within 30 minutes, soothe them and repeat the dose. Do not double the dose if it's nearly time for the next scheduled dose. Temporary side effects like headache, constipation, diarrhea, and fatigue may occur, typically resolving as your child adjusts to the medication. Persistent or troublesome side effects warrant immediate medical attention. Disclose all medications your child takes, including analgesics, antibiotics, and antidepressants, as well as any history of liver or kidney issues, gastrointestinal obstructions, heart conditions, or allergies to medications, ingredients, or foods. This information is crucial for accurate dosing and treatment planning.
Primary Ingredients of Vomikind-MD 2 Tablet
No information provided. Please provide the text you wish to be rewritten.
Uses of Vomikind-MD 2 Tablet
Managing Vomiting and Nausea
Major Benefits of Vomikind-MD 2 Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Avoid handling the tablets with damp hands. Allow the Vomikind-MD 2 Tablet to dissolve in your mouth; do not ingest it whole. This medication can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Vomikind-MD 2 Tablet:
- Headache
- Constipation
- Diarrhea
- Fatigue
How to use Vomikind-MD 2 Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Avoid contact with the tablets using damp hands. Place the tablet in your mouth for dissolution; refrain from immediate swallowing. Vomikind-MD 2 Tablet can be ingested with or without food, although consistent timing is recommended.
How Vomikind-MD 2 Tablet works:
Prior to procedures like radiotherapy, chemotherapy, abdominal surgery, or other major operations, dying cells release serotonin into the bloodstream. This serotonin triggers the body's emetic centers, potentially causing nausea and vomiting in your child. Administering one Vomikind-MD 2 Tablet pre-procedure helps prevent vomiting by blocking serotonin's action on these brain centers.
SAFETY ADVICE
AlcoholCAUTION
Patients should exercise caution when using Vomikind-MD 2 Tablet concurrently with alcohol. A physician's consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Data on Vomikind-MD 2 Tablet use in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Vomikind-MD 2 Tablet with breastfeeding is lacking. Seek medical advice from your physician.
DrivingCONSULT YOUR DOCTOR
The effect of Vomikind-MD 2 Tablet on driving ability is unknown. Refrain from operating a vehicle if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Use of Vomikind-MD 2 Tablet is considered safe for individuals with kidney impairment. No modification to the Vomikind-MD 2 Tablet dosage is necessary.
LiverCAUTION
Patients with liver impairment should use Vomikind-MD 2 Tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Vomikind-MD 2 Tablet :
Remain calm. Administer the forgotten dose immediately upon recollection. Nevertheless, omit the missed dose if the next scheduled dose is imminent. Avoid doubling the dose and adhere to the recommended dosage regimen.
Facts to Know About Vomikind-MD 2 Tablet
| Label | Value |
|---|---|
| Chemical Type | Carbazole-based compound |
| Developing Good Habits | No. |
| Treatment Category | Digestive |





